fusarium has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lin, J; Liu, YG; Yang, LY; Zhou, B; Zhu, BQ | 1 |
Agoglia, L; Alves, J; Araujo, A; Balbi, E; Carius, L; Covelo, M; Enne, M; Gonzalez, AC; Guedes, C; Halpern, M; Martinho, JM; Pacheco, L; Roma, J | 1 |
2 other study(ies) available for fusarium and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
Article | Year |
---|---|
H1-A, a compound isolated from Fusarium oxysporum inhibits hepatitis C virus (HCV) NS3 serine protease.
Topics: Enzyme Inhibitors; Fusarium; Hepacivirus; Hepatitis C; Humans; Magnetic Resonance Spectroscopy; Viral Nonstructural Proteins | 2016 |
Cellulitis and nodular skin lesions due to Fusarium spp in liver transplant: case report.
Topics: Amphotericin B; Biopsy; Cellulitis; Fusarium; Graft Rejection; Hepatitis C; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole | 2010 |